United Health Products, Inc. (UEEC)
- Previous Close
0.1250 - Open
0.1398 - Bid --
- Ask --
- Day's Range
0.1349 - 0.1616 - 52 Week Range
0.0460 - 0.2850 - Volume
210,095 - Avg. Volume
117,631 - Market Cap (intraday)
41.656M - Beta (5Y Monthly) -1.36
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.
uhpcorp.comRecent News: UEEC
View MorePerformance Overview: UEEC
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UEEC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UEEC
View MoreValuation Measures
Market Cap
41.55M
Enterprise Value
42.49M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-1,136.45%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.08M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
4.91k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
40.7k